Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Delbar Daneshjou"'
Autor:
Shahrzad Zadeh Modarres, Delbar Daneshjou, Malek Soleimani Mehranjani, Seyed Mohammad Ali Shariatzadeh
Publikováno v:
Indian Journal of Medical Research. 157:66-73
Autor:
Delbar Daneshjou, Malek Soleimani Mehranjani, Shahrzad Zadehmodarres, Seyed Mohammad Ali Shariatzadeh, Zahra Shams Mofarahe
Publikováno v:
Journal of reproductive immunology. 150
The aim of this study was to investigate the effects of sitagliptin/metformin (sitaformin), metformin and sitagliptin in PCOS patients. PCOS is a hormonal disorder and therefore the use of treatments that modulate hormone levels Like AMH, testosteron
Autor:
Malek Soleimani Mehranjani, Delbar Daneshjou, Mohammad Ali Shariatzadeh, Shahrzad Zadeh Modarres
Publikováno v:
Trends in endocrinology and metabolism: TEM. 31(12)
Metformin has long been used in the treatment of polycystic ovarian syndrome (PCOS). Recently, sitagliptin has been reported to improve ovarian cycles and ovulation in PCOS. We suggest that a combination of sitagliptin and metformin can be more effec
Autor:
Delbar Daneshjou, Malek Soleimani Mehranjani, Shahrzad Zadeh Modarres, Seyed Mohammad Ali Shariat Zadeh
Publikováno v:
Irish journal of medical science. 190(2)
Insulin resistance plays a major role in the pathogenesis of polycystic ovary syndrome (PCOS). Therefore, there is a growing interest in the use of insulin sensitizer drugs in the treatment of PCOS. Research in recent years has shown that sitagliptin